Abuse of anabolic‐androgenic steroids and bodybuilding acne: an underestimated health problem

Abuse of anabolic‐androgenic steroids (AAS) by members of fitness centers and others in Germany has reached alarming dimensions. The health care system provides the illegal AAS to 48.1 % of abusers. Physicians are involved in illegal prescription of AAS and monitoring of 32.1 % of AAS abusers. Besides health‐threatening cardiovascular, hepatotoxic and psychiatric long‐term side effects of AAS, acne occurs in about 50 % of AAS abusers and is an important clinical indicator of AAS abuse, especially in young men 18‐26 years of age. Both acne conglobata and acne fulminans can be induced by AAS abuse. The dermatologist should recognize bodybuilding acne, address the AAS abuse, and warn the patient about other potential hazards.

[1]  W. Schänzer,et al.  Doping im Sport , 2007, Medizinische Klinik.

[2]  I. Riezzo,et al.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders , 2006, International Journal of Legal Medicine.

[3]  E. J. Parry,et al.  Acne induced by ‘Sus’ and ‘Deca’ , 2006, Clinical and experimental dermatology.

[4]  H. Druid,et al.  Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids. , 2006, Drug and alcohol dependence.

[5]  K. Dietz,et al.  Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. , 2006, Drug and alcohol dependence.

[6]  Takashi Sato,et al.  Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. , 2005, The Journal of investigative dermatology.

[7]  C. Zouboulis Sebaceous glands and the prostaglandin pathway--key stones of an exciting mosaic. , 2005, The Journal of investigative dermatology.

[8]  K. Johns,et al.  Anabolic steroids for the treatment of weight loss in HIV-infected individuals. , 2005, The Cochrane database of systematic reviews.

[9]  M. Link,et al.  Cardiovascular toxicities of performance-enhancing substances in sports. , 2005, Mayo Clinic proceedings.

[10]  Paul J Perry,et al.  Anabolic Steroid Use in Weightlifters and Bodybuilders: An Internet Survey of Drug Utilization , 2005, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[11]  G. Colditz,et al.  Exposure to the Mass Media, Body Shape Concerns, and Use of Supplements to Improve Weight and Shape Among Male and Female Adolescents , 2005, Pediatrics.

[12]  R. C. Hall,et al.  Psychiatric complications of anabolic steroid abuse. , 2005, Psychosomatics.

[13]  J. H. Hoffman,et al.  Adolescent Anabolic Steroid Use, Gender, Physical Activity, and Other Problem Behaviors , 2005, Substance use & misuse.

[14]  A. Boschnakow,et al.  Zileuton, an Oral 5-Lipoxygenase Inhibitor, Directly Reduces Sebum Production , 2004, Dermatology.

[15]  C. Zouboulis Acne and sebaceous gland function. , 2004, Clinics in dermatology.

[16]  A. Rane,et al.  The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology , 2003, European Journal of Clinical Pharmacology.

[17]  H. Pope,et al.  Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. , 2003, Drug and alcohol dependence.

[18]  H. Gollnick,et al.  Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. , 2003, Journal of the American Academy of Dermatology.

[19]  W. Cunliffe,et al.  A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. , 2003, Archives of dermatology.

[20]  P. Elsner,et al.  Sport als Risikofaktor und therapeutisches Prinzip in der Dermatologie , 2002, Der Hautarzt.

[21]  B. Fridlund,et al.  The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. , 2001, European journal of public health.

[22]  G. Kanayama,et al.  Over-the-Counter Drug Use in Gymnasiums: An Underrecognized Substance Abuse Problem? , 2001, Psychotherapy and Psychosomatics.

[23]  P. Sanz,et al.  Cryofibrinogenaemia with a good response to stanozolol , 2000, Clinical and experimental dermatology.

[24]  R. Day,et al.  Anabolic‐androgenic steroids: medical assessment of present, past and potential users , 2000, The Medical journal of Australia.

[25]  R. Rosenfield,et al.  Role of hormones in pilosebaceous unit development. , 2000, Endocrine reviews.

[26]  H. Pope,et al.  Anabolic-androgenic steroids as a gateway to opioid dependence. , 2000, The New England journal of medicine.

[27]  D. Mackinnon,et al.  The adolescents training and learning to avoid steroids program: preventing drug use and promoting health behaviors. , 2000, Archives of pediatrics & adolescent medicine.

[28]  D. Orgill,et al.  The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. , 2000, Journal of critical care.

[29]  H. Sachs,et al.  Testing for anabolic steroids in hair from two bodybuilders. , 1999, Forensic science international.

[30]  A. Kentsis,et al.  Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. , 1999, The Journal of investigative dermatology.

[31]  M. Van Loan,et al.  Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[32]  A. Roberts,et al.  Stimulation of collagen synthesis by the anabolic steroid stanozolol. , 1998, The Journal of investigative dermatology.

[33]  G. Pierard L'image du mois : Acne gymnasium : une acné fulminante dopée , 1998 .

[34]  B. Maycock,et al.  Current perspectives on anabolic steroids. , 1998, Drug and alcohol review.

[35]  B. Towler,et al.  General practitioners' views and knowledge about anabolic steroid use--survey of GPs in a high prevalence area. , 1997, Drug and alcohol review.

[36]  G. Stimson,et al.  Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. , 1997, International journal of sports medicine.

[37]  David Handelsman,et al.  Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. , 1997, International journal of andrology.

[38]  D. Mackinnon,et al.  Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. , 1996, JAMA.

[39]  W. Wahli,et al.  The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.

[40]  Pirkko Korkia,et al.  Use of anabolic steroids has been reported by 9% of men attending gymnasiums , 1996, BMJ.

[41]  J. Gold,et al.  Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection , 1996, AIDS.

[42]  J. Lear,et al.  Anabolic steroids and psoriasis exacerbation , 1996, The British journal of dermatology.

[43]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[44]  T. Helfman,et al.  Stanozolol as a novel therapeutic agent in dermatology. , 1995, Journal of the American Academy of Dermatology.

[45]  A. Lucky,et al.  Hormonal correlates of acne and hirsutism. , 1995, The American journal of medicine.

[46]  M. Debackere,et al.  The Abuse of Doping Agents in Competing Body Builders in Flanders (1988-1993) , 1995, International journal of sports medicine.

[47]  S. Liao,et al.  Androgen receptor expression in the preputial gland and its sebocytes. , 1994, The Journal of investigative dermatology.

[48]  P. Hull,et al.  Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). , 1994, Journal of the American Academy of Dermatology.

[49]  R. Durant,et al.  Use of multiple drugs among adolescents who use anabolic steroids. , 1993, The New England journal of medicine.

[50]  N. Penneys,et al.  Immunohistochemical distribution of aromatase and 3B‐hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland , 1992, Journal of cutaneous pathology.

[51]  M. J. Scott,et al.  Effects of anabolic-androgenic steroids on the pilosebaceous unit. , 1992, Cutis.

[52]  V. Rickert,et al.  Adolescent body image and attitudes to anabolic steroid use. , 1992, American journal of diseases of children.

[53]  O. Trygstad,et al.  Acne in pubertal boys undergoing treatment with androgens. , 1992, Acta dermato-venereologica.

[54]  L. Rossi Bernardi,et al.  Evaluation of prevalence of "doping" among Italian athletes , 1990, The Lancet.

[55]  M. Johnson,et al.  Anabolic steroid use in adolescent athletes. , 1990, Pediatric clinics of North America.

[56]  W. Yates,et al.  Illicit anabolic steroid use in athletes , 1990, The American journal of sports medicine.

[57]  M. Landthaler,et al.  [Acne conglobata-like exacerbation of acne vulgaris following administration of anabolic steroids and vitamin B complex-containing preparations]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[58]  E. Nieschlag,et al.  Anabolic steroids and semen parameters in bodybuilders. , 1989, Fertility and sterility.

[59]  K. Friedl,et al.  Anabolic Steroid Use: Indications of Habituation among Adolescents , 1989, Journal of drug education.

[60]  V. Rickert,et al.  Anabolic steroid use by male adolescents. , 1989, Pediatrics.

[61]  G. Heydenreich Testosterone and anabolic steroids and acne fulminans. , 1989, Archives of dermatology.

[62]  K. Friedl,et al.  Estimated prevalence of anabolic steroid use among male high school seniors. , 1988, JAMA.

[63]  D. Katz,et al.  Anabolic-Androgenic Steroid Use Among 1,010 College Men. , 1988, The Physician and sportsmedicine.

[64]  R. Happle,et al.  Acne of the fulminans type following testosterone therapy in three excessively tall boys. , 1988, Archives of dermatology.

[65]  Y. Collan,et al.  Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. , 1987, The American Journal of dermatopathology.

[66]  W. Cunliffe,et al.  Is increased 5 alpha-reductase activity a primary phenomenon in androgen-dependent skin disorders? , 1987, The Journal of investigative dermatology.

[67]  M. Alen,et al.  Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. , 1987, Acta dermato-venereologica.

[68]  J. V. Toohey,et al.  Non-medical drug use behaviour at five United States universities: a 15-year study. , 1985, Bulletin on narcotics.

[69]  J. Gustafsson,et al.  Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. , 1984, Endocrinology.

[70]  W. Cunliffe,et al.  The Relationship Between the In Vitro Activity of 3β-Hydroxysteroid Dehydrogenase Δ4–5-Isomerase in Human Sebaceous Glands and Their Secretory Activity In Vivo , 1983 .

[71]  M. Tóth,et al.  Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone , 1982 .

[72]  G. Plewig,et al.  Hamster ear model for sebaceous glands. , 1977, The Journal of investigative dermatology.

[73]  G. Sansone,et al.  Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin--a possible pathogenic factor in acne. , 1971, The Journal of investigative dermatology.

[74]  A. Lenzi,et al.  Biochemical evidence supporting the Cortina criteria. , 2005 .

[75]  A. Lenzi,et al.  Androgenic-anabolic steroids abuse in males. , 2005, Journal of endocrinological investigation.

[76]  Harm Kuipers,et al.  Effects of Androgenic-Anabolic Steroids in Athletes , 2004, Sports medicine.

[77]  G. Plewig Akne und Rosazea , 1994 .

[78]  M. J. Scott,et al.  Linear keloids resulting from abuse of anabolic androgenic steroid drugs. , 1994, Cutis.

[79]  E. Wilson,et al.  The androgen receptor: an overview. , 1994, Recent progress in hormone research.

[80]  W. Bartsch Anabolic steroids--action on cellular level. , 1993, Wiener medizinische Wochenschrift.

[81]  R. Terney,et al.  The use of anabolic steroids in high school students. , 1990, American journal of diseases of children.

[82]  A. A. Hartmann,et al.  Acne fulminans bei Klinefelter-Syndrom unter Testosteron. Eine Nebenwirkung der Antihochwuchstherapie , 1989 .

[83]  M. Alen,et al.  The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacteria acnes in young postpubertal men. , 1988, Acta dermato-venereologica.

[84]  D. MacDougall Anabolic Steroids. , 1983, The Physician and sportsmedicine.